CONTINUOUS PRODUCTION OF RALOXIFENE HYDROCHLORIDE LOADED NANOSTRUCTURED LIPID CARRIERS USING HOT-MELT EXTRUSION TECHNOLOGY.

extended drug release hot-melt extrusion nanostructured lipid carriers probe sonication raloxifene hydrochloride

Journal

Journal of drug delivery science and technology
ISSN: 1773-2247
Titre abrégé: J Drug Deliv Sci Technol
Pays: France
ID NLM: 101214432

Informations de publication

Date de publication:
Oct 2021
Historique:
entrez: 26 7 2021
pubmed: 27 7 2021
medline: 27 7 2021
Statut: ppublish

Résumé

The aim of this study was to utilize a continuous process for the production of orally administered raloxifene hydrochloride (RX-HCl) loaded nanostructured lipid carrier (NLC) formulations for extended drug release using hot-melt extrusion (HME) technology coupled with probe sonication, and also to evaluate the

Identifiants

pubmed: 34306183
doi: 10.1016/j.jddst.2021.102673
pmc: PMC8294163
mid: NIHMS1723345
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIGMS NIH HHS
ID : P30 GM122733
Pays : United States

Déclaration de conflit d'intérêts

CONFLICT OF INTEREST Declarations of interest: none

Références

Int J Pharm. 2013 Aug 30;453(1):233-52
pubmed: 23178213
Expert Opin Drug Deliv. 2012 Jan;9(1):105-25
pubmed: 22145932
AAPS J. 2015 Jan;17(1):194-205
pubmed: 25344439
AAPS PharmSciTech. 2016 Feb;17(1):133-47
pubmed: 26729533
Drug Dev Ind Pharm. 2007 Oct;33(10):1043-57
pubmed: 17963112
Colloids Surf B Biointerfaces. 2005 Nov 10;45(3-4):167-73
pubmed: 16198092
Int J Pharm. 2013 Sep 15;454(1):573-83
pubmed: 23535345
J Adv Res. 2016 May;7(3):423-34
pubmed: 27222747
Biomed Res Int. 2013;2013:584549
pubmed: 24228255
J Pharm Sci. 2017 Apr;106(4):1085-1091
pubmed: 28040458
Eur J Pharm Biopharm. 2002 Sep;54(2):107-17
pubmed: 12191680
Int J Pharm. 2014 Aug 25;471(1-2):153-6
pubmed: 24853459
Int J Pharm. 2015 Dec 30;496(1):33-41
pubmed: 25863118
Drug Dev Ind Pharm. 2007 Sep;33(9):909-26
pubmed: 17891577
Chem Pharm Bull (Tokyo). 1995 Aug;43(8):1412-5
pubmed: 7553988
Eur J Pharm Sci. 2012 Aug 30;47(1):139-51
pubmed: 22664358
Int J Nanomedicine. 2012;7:3787-802
pubmed: 22888234
J Young Pharm. 2011 Jul;3(3):216-20
pubmed: 21897661
Antiinflamm Antiallergy Agents Med Chem. 2019;18(1):26-44
pubmed: 30430947
Expert Opin Drug Deliv. 2008 Dec;5(12):1357-76
pubmed: 19040397
AAPS PharmSciTech. 2016 Feb;17(1):20-42
pubmed: 26159653

Auteurs

Derick Muhindo (D)

Department of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, University, Mississippi 38677.

Eman A Ashour (EA)

Department of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, University, Mississippi 38677.

Mashan Almutairi (M)

Department of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, University, Mississippi 38677.
Department of Pharmaceutics, College of Pharmacy, University of Hail, Hail, 81442, Saudi Arabia.

Poorva H Joshi (PH)

Department of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, University, Mississippi 38677.

Michael A Repka (MA)

Department of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, University, Mississippi 38677.
Pii Center for Pharmaceutical Technology, School of Pharmacy, University of Mississippi, University, Mississippi 38677.

Classifications MeSH